التفاصيل البيبلوغرافية
| العنوان: |
Flavonoid Derivatives as New Potent Inhibitors of Cysteine Proteases: An Important Step toward the Design of New Compounds for the Treatment of Leishmaniasis. |
| المؤلفون: |
Lourenço, Estela Mariana Guimarães, Di Iório, Juliana Fortes, da Silva, Fernanda, Fialho, Felipe Leonardo Bley, Monteiro, Melquisedeque Mateus, Beatriz, Adilson, Perdomo, Renata Trentin, Barbosa, Euzébio Guimarães, Oses, Jean Pierre, de Arruda, Carla Cardozo Pinto, de Souza Júdice, Wagner Alves, Rafique, Jamal, de Lima, Dênis Pires |
| المصدر: |
Microorganisms; Jan2023, Vol. 11 Issue 1, p225, 23p |
| مصطلحات موضوعية: |
CYSTEINE proteinases, FLAVONOIDS, LEISHMANIASIS, NEGLECTED diseases, CYSTEINE proteinase inhibitors |
| الشركة/الكيان: |
UNITED Nations |
| مستخلص: |
Leishmaniasis is a neglected tropical disease, affecting more than 350 million people globally. However, there is currently no vaccine available against human leishmaniasis, and current treatment is hampered by high cost, side-effects, and painful administration routes. It has become a United Nations goal to end leishmaniasis epidemics by 2030, and multitarget drug strategy emerges as a promising alternative. Among the multitarget compounds, flavonoids are a renowned class of natural products, and a structurally diverse library can be prepared through organic synthesis, which can be tested for biological effectiveness. In this study, we synthesised 17 flavonoid analogues using a scalable, easy-to-reproduce, and inexpensive method. All synthesised compounds presented an impressive inhibition capacity against rCPB2.8, rCPB3, and rH84Y enzymes, which are highly expressed in the amastigote stage, the target form of the parasite. Compounds 3c, f12a, and f12b were found to be effective against all isoforms. Furthermore, their intermolecular interactions were also investigated through a molecular modelling study. These compounds were highly potent against the parasite and demonstrated low cytotoxic action against mammalian cells. These results are pioneering, representing an advance in the investigation of the mechanisms behind the antileishmanial action of flavonoid derivatives. Moreover, compounds have been shown to be promising leads for the design of other cysteine protease inhibitors for the treatment of leishmaniasis diseases. [ABSTRACT FROM AUTHOR] |
|
Copyright of Microorganisms is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder